CoreCivic, one of the largest private detention companies in the country, is expecting a boom in business due to Trump policy changes.

So far during his second term, Ciscomani has generally been supportive of President Donald Trump’s agenda, particularly Trump’s “DOGE” effort to slash the size of the federal budget and an executive ...

CoreCivic reports fourth-quarter revenue of $479.3 million, beating analyst estimates of $465.17 million. CoreCivic reports fourth-quarter funds from operations (FFO) of 39 cents per share ...

Pre-earnings options volume in CoreCivic (CXW) is 1.4x normal with calls leading puts 11:2. Implied volatility suggests the market is anticipating a move near 8.2%, or $1.54, after results are ...

CoreCivic Inc is set to release its Q4 2024 earnings on Feb 11, 2025.The consensus estimate for Q4 2024 revenue is $465.17 million, and the earnings are expected to come in at $0.10 per share. The ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on CXW: CoreCivic NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Based on the one-year price targets offered by 5 analysts, the average target price for CoreCivic Inc (NYSE:CXW) is $26.40 with a high estimate of $32.00 and a low estimate of $17.00. The average ...

Hininger, CoreCivic's Chief Executive Officer, commented, "We closed 2024 with strong financial performance. We look forward to the future, which we anticipate will be a period of accelerated ...

Hininger, CoreCivic's Chief Executive Officer, commented, "We closed 2024 with strong financial performance. We look forward to the future, which we anticipate will be a period of accelerated demand ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

AZ acquired rights to Andexxa through its $39 billion takeover in 2021 of Alexion, which in turn claimed ownership when it bought Portola Pharma in 2020 for $1.4 billion. The drug makes relatively ...